SORGEM Evaluation acted as an independent expert in connection with the internal reorganisation of a pharmaceutical group.

13 March 2024 - Actualité Sorgem Évaluation

SORGEM EVALUATION acted as a financial expert as part of an internal reorganisation of a pharmaceutical group, with a view to reviewing the valuation of the manufacturing and commercial companies to be transferred within the group.

Article précédent Article suivant

Actualités

Proposed public buy-out offer by the SMABTP Group – Appointment of Sorgem Evaluation

Proposed public withdrawal offer by the SMABTP Group for Société de la Tour Eiffel at a price of 8.20 euros

2 April 2026

Lire

Actualités

Unfair competition: Judgment of the Paris Court of Appeal in the dispute between Tediber and Emma

In its judgement of 2 April 2025 (Case No. RG 23/05696), the Paris Court of Appeal held that EMMA was

10 April 2025

Lire

Actualités

Sorgem Evaluation was commissioned to model the risk analysis calculations carried out by Euronext

Sorgem Evaluation recently assisted a client who, as part of its derivatives business, needed to switch to the Euronext clearing

10 March 2025

Lire

Ces articles pourraient vous intéresser

Proposed public buy-out offer by the SMABTP Group – Appointment of Sorgem Evaluation

Unfair competition: Judgment of the Paris Court of Appeal in the dispute between Tediber and Emma

Sorgem Evaluation was commissioned to model the risk analysis calculations carried out by Euronext

Have a question or a need?